Royal Philips/$PHG
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Royal Philips
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
Ticker
$PHG
Sector
Primary listing
NYSE
Employees
67,035
Headquarters
Website
Royal Philips Metrics
BasicAdvanced
$27B
136.99
$0.21
0.91
$0.82
2.92%
Price and volume
Market cap
$27B
Beta
0.91
52-week high
$29.29
52-week low
$20.77
Average daily volume
877K
Dividend rate
$0.82
Financial strength
Current ratio
1.32
Quick ratio
0.744
Long term debt to equity
68.383
Total debt to equity
79.231
Dividend payout ratio (TTM)
198.79%
Interest coverage (TTM)
5.43%
Profitability
EBITDA (TTM)
2,389.308
Gross margin (TTM)
43.49%
Net profit margin (TTM)
0.93%
Operating margin (TTM)
8.40%
Effective tax rate (TTM)
79.16%
Revenue per employee (TTM)
$312,250
Management effectiveness
Return on equity (TTM)
1.54%
Valuation
Price to earnings (TTM)
136.99
Price to revenue (TTM)
1.271
Price to book
2.19
Price to tangible book (TTM)
-16.89
Price to free cash flow (TTM)
38.577
Free cash flow yield (TTM)
2.59%
Free cash flow per share (TTM)
0.73
Dividend yield (TTM)
2.92%
Forward dividend yield
2.92%
Growth
Revenue change (TTM)
-1.44%
Earnings per share change (TTM)
-149.48%
3-year revenue growth (CAGR)
0.82%
10-year revenue growth (CAGR)
-2.83%
3-year earnings per share growth (CAGR)
-50.37%
10-year earnings per share growth (CAGR)
-14.30%
What the Analysts think about Royal Philips
Analyst ratings (Buy, Hold, Sell) for Royal Philips stock.
Bulls say / Bears say
In Q2 2025, Philips delivered a 12.4% adjusted EBITA margin, surpassing analysts’ average forecast of 9.9%, driven by innovation, product mix, and productivity improvements that showcased strong operational leverage. (Reuters)
Philips recorded a 6% increase in comparable order intake in Q2 2025, fueled by AI-powered diagnostic systems and bolstered by a long-term agreement with Indonesia’s Ministry of Health for its Azurion image-guided therapy system, underscoring robust demand momentum. (Reuters)
Following the US-EU trade agreement, Philips reduced its estimated tariff impact to €150-200 million from €250-300 million and raised its core EBITA margin forecast for 2025 to 11.3%-11.8%, demonstrating effective cost mitigation and resilience against trade headwinds. (Reuters)
The US FDA issued a warning letter to three Philips device production facilities for failing to meet manufacturing standards, leading to a nearly 5% drop in US‐listed shares and highlighting potential quality control and regulatory risks. (Reuters)
Paris prosecutors opened a criminal probe into Philips over its 2021 sleep apnea device recall, investigating potential aggravated fraud and failure to report safety incidents that could result in hefty fines and reputational damage. (Reuters)
In May 2025, Philips cut its full-year adjusted EBITA margin forecast to 10.8%-11.3% due to an anticipated €250-300 million net tariff impact, signaling earnings pressure from ongoing trade tensions. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 4 Nov 2025.
Royal Philips Financial Performance
Revenues and expenses
Royal Philips Earnings Performance
Company profitability
Royal Philips News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Royal Philips stock?
Royal Philips (PHG) has a market cap of $27B as of November 11, 2025.
What is the P/E ratio for Royal Philips stock?
The price to earnings (P/E) ratio for Royal Philips (PHG) stock is 136.99 as of November 11, 2025.
Does Royal Philips stock pay dividends?
Yes, the Royal Philips (PHG) stock pays dividends to shareholders. As of November 11, 2025, the dividend rate is $0.8222 and the yield is 2.92%. Royal Philips has a payout ratio of 198.79% on a trailing twelve-month basis.
When is the next Royal Philips dividend payment date?
The next Royal Philips (PHG) dividend payment date is unconfirmed.
What is the beta indicator for Royal Philips?
Royal Philips (PHG) has a beta rating of 0.91. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.